APA (7th ed.) Citation

Mancini, L., Casagranda, S., Gautier, G., Peter, P., Lopez, B., Thorne, L., . . . Bisdas, S. (2022). Correction to: CEST MRI provides amide/amine surrogate biomarkers for treatment‑naïve glioma sub‑typing. European Journal of Nuclear Medicine & Molecular Imaging, 49(7), 2454. https://doi.org/10.1007/s00259-022-05798-6

Chicago Style (17th ed.) Citation

Mancini, Laura, et al. "Correction to: CEST MRI Provides Amide/amine Surrogate Biomarkers for Treatment‑naïve Glioma Sub‑typing." European Journal of Nuclear Medicine & Molecular Imaging 49, no. 7 (2022): 2454. https://doi.org/10.1007/s00259-022-05798-6.

MLA (9th ed.) Citation

Mancini, Laura, et al. "Correction to: CEST MRI Provides Amide/amine Surrogate Biomarkers for Treatment‑naïve Glioma Sub‑typing." European Journal of Nuclear Medicine & Molecular Imaging, vol. 49, no. 7, 2022, p. 2454, https://doi.org/10.1007/s00259-022-05798-6.